Equities

Pell Bio Med Technology Co Ltd

6949:TAI

Pell Bio Med Technology Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)82.00
  • Today's Change0.90 / 1.11%
  • Shares traded11.00k
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,106708116
Total Receivables, Net7.946.4111
Total Inventory3.764.584.24
Prepaid expenses8.865.841.10
Other current assets, total0.650.160.08
Total current assets1,127725132
Property, plant & equipment, net261299250
Goodwill, net------
Intangibles, net2.402.711.47
Long term investments0.370.260.26
Note receivable - long term------
Other long term assets221711
Total assets1,4181,044394
LIABILITIES
Accounts payable6.995.728.61
Accrued expenses401519
Notes payable/short-term debt05.000
Current portion long-term debt/capital leases252511
Other current liabilities, total176.865.62
Total current liabilities895744
Total long term debt147173125
Total debt173203136
Deferred income tax------
Minority interest11140.01
Other liabilities, total------
Total liabilities248243169
SHAREHOLDERS EQUITY
Common stock539444334
Additional paid-in capital1,44977477
Retained earnings (accumulated deficit)(818)(417)(186)
Treasury stock - common(0.8)----
Unrealized gain (loss)------
Other equity, total------
Total equity1,170801225
Total liabilities & shareholders' equity1,4181,044394
Total common shares outstanding544646
Treasury shares - common primary issue0.0400
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.